☆ 4.8 Editorial Material

Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease

CIRCULATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study

Oluwadolapo D. Lawal et al.

Summary: This study compared the effectiveness and safety of direct oral anticoagulants (DOACs) with warfarin in patients with atrial fibrillation (AF) and chronic liver disease. The results showed that DOACs as a class were associated with lower risks of hospitalization for ischemic stroke/systemic embolism and major bleeding compared to warfarin. However, the outcomes varied between different DOACs and in head-to-head comparisons with warfarin.

CIRCULATION (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis

Erica Villa et al.

Summary: This article discusses the challenging issues of bleeding and thrombosis prevention and management in patients with cirrhosis, providing practical guidance. Some recommendations in this document are based on the panel's view that certain commonly used interventions are not useful.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Thromboembolism and bleeding in patients with atrial fibrillation and liver disease- A nationwide register-based cohort study Thromboembolism and bleeding in liver disease

Kamilla Steensig et al.

Summary: This study examined the risks of thromboembolism and bleeding in patients with liver disease and atrial fibrillation/flutter who used or did not use oral anticoagulation. The results showed that oral anticoagulant initiation was associated with a reduced thromboembolism risk in patients with liver disease and high CHA2DS2-VASc-score.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study

Marco Proietti et al.

Summary: Patients with atrial fibrillation and concomitant liver disease have increased risks of stroke, major bleeding, and all-cause death. However, the use of oral anticoagulant drugs can significantly reduce these risks and provide a positive benefit-risk ratio.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

Robert S. O'Shea et al.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review

Yonghui Fu et al.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Craig T. January et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Jan Steffel et al.

EUROPEAN HEART JOURNAL (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Daniele Pastori et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver

Rohitash Jamwal et al.

MOLECULAR PHARMACEUTICS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor

Dagmar Kubitza et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)

添加到收藏夹

Article Medicine, General & Internal

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Medicine, General & Internal

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Medicine, General & Internal

Dabigatran versus Warfarin in Patients with Atrial Fibrillation.

Stuart J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.